Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | BMY:NYQ since announced | Transaction value |
---|---|---|
RayzeBio Inc | -20.56% | 4.21bn |
Karuna Therapeutics Inc | -18.96% | 14.40bn |
LianBio-Mavacamten Greater China Rights | -25.82% | 350.00m |
Mirati Therapeutics Inc | -26.69% | 5.12bn |
Data delayed at least 15 minutes, as of May 24 2024 00:00 BST.
Holder | Shares | % Held |
---|---|---|
Bram Bradesco Asset Management S/A DTVMas of 31 Jan 2024 | 4.73k | 0.00% |
Data from 31 Jan 2024 - 31 Jan 2024Source: FactSet Research Systems Inc.